Natco Pharma Ltd today said it has commenced commercial production at its Dehradun unit.
The company informed the Bombay Stock Exchange that the finished dosage pharmacuetical formulations unit would achieve a capacity level of 300 million tablets per annum and the project is being implemented in stages.
AdvertisementPlans of establishing a parenterals division at Dehradun are also underway, it added.
The share of the company was trading at Rs 102.35, down 4.48 per cent on the BSE.
You May Also Like